The Board of Directors of Nureca Limited, in their meeting held on May 29, 2026, approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. Additionally, the Board approved the appointment of Mr. Chander Kant as the new Chief Financial Officer (CFO) effective June 27, 2026, following the resignation of Mr. Naresh Gupta. Other key developments include the re-appointment of Mr. Aryan Goyal as Whole-time Director & CEO, Mr. Saurabh Goyal as Managing Director, and the appointment of Ms. Smita Goyal as an Additional Director. The Board also approved an incremental capital expenditure of up to 100 Crores for manufacturing expansion at the company’s facility in Sundran, Punjab.

Nureca Limited is a prominent player in the digital healthcare and wellness sector, known for its brand “Dr Trust,” which offers a wide range of home healthcare devices, wellness products, and hygiene solutions. The company has been recognized as a “Great Place to Work” for the year 2025. During the year, Nureca undertook a strategic buyback of equity shares via a tender offer route and has filed a Scheme of Merger by Absorption to merge its wholly-owned subsidiary, Nureca Technologies Private Limited, with the parent company.

In the quarter ended March 31, 2026, Nureca Limited reported standalone revenue from operations of 396.40 Million, compared to 354.05 Million in the previous quarter and 317.50 Million in the corresponding quarter of the previous year. The profit after tax for the current quarter stood at (66.25) Million, against a profit of 32.31 Million in the preceding quarter and 20.72 Million in the same quarter of the previous year.